Published in:
01-04-2013 | Original Paper
Fargesin, a component of Flos Magnoliae, stimulates glucose uptake in L6 myotubes
Authors:
Sun-Sil Choi, Byung-Yoon Cha, Bong-Keun Choi, Young-Sil Lee, Takayuki Yonezawa, Toshiaki Teruya, Kazuo Nagai, Je-Tae Woo
Published in:
Journal of Natural Medicines
|
Issue 2/2013
Login to get access
Abstract
Flos Magnoliae (FM) is a commonly used Chinese medicinal herb for symptomatic relief of allergic rhinitis, sinusitis and headache. Although several FM species have been used as substitutes or adulterants for clinical use, possible differences in their pharmacological actions have not been reported. To confirm the effects of FM on skeletal muscle glucose metabolism, we tested the effects of several compounds isolated from FM on glucose uptake by L6 myotubes. We found that fargesin, a component of FM, dose-dependently stimulated glucose consumption in L6 myotubes, which was accompanied by enhanced glucose transporter (GLUT)-4 translocation to the cell surface. Fargesin-stimulated glucose uptake was blocked by wortmannin, a phosphatidylinositol-3 kinase (PI3 K) inhibitor. Fargesin stimulated Akt phosphorylation, a key component in the insulin signaling pathway, which was completely inhibited by wortmannin. Here, we demonstrated that fargesin, a bioactive component of Flos Magnoliae, increases basal glucose uptake and GLUT4 translocation in L6 myotubes by activating the PI3 K–Akt pathway.